Free Trial

NVE (NVEC) Financials

NVE logo
$116.92 +3.07 (+2.70%)
Closing price 04:00 PM Eastern
Extended Trading
$116.87 -0.05 (-0.04%)
As of 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for NVE

Annual Income Statements for NVE

This table shows NVE's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 3/31/2022 3/31/2023 3/31/2024
Net Income / (Loss) Attributable to Common Shareholders
15 23 17
Consolidated Net Income / (Loss)
15 23 17
Net Income / (Loss) Continuing Operations
15 23 17
Total Pre-Tax Income
17 27 20
Total Operating Income
16 26 19
Total Gross Profit
21 30 23
Total Revenue
27 38 30
Operating Revenue
27 38 30
Total Cost of Revenue
6.26 8.06 6.78
Operating Cost of Revenue
6.26 8.06 6.77
Other Cost of Revenue
- 0.00 0.01
Total Operating Expenses
4.40 4.55 4.50
Selling, General & Admin Expense
1.47 1.96 1.77
Research & Development Expense
2.93 2.58 2.73
Total Other Income / (Expense), net
1.17 1.45 1.95
Interest & Investment Income
1.17 1.45 1.95
Income Tax Expense
2.99 4.40 3.34
Basic Earnings per Share
$3.00 $4.70 $3.54
Weighted Average Basic Shares Outstanding
4.83M 4.83M 4.83M
Diluted Earnings per Share
$3.00 $4.70 $3.54
Weighted Average Diluted Shares Outstanding
4.84M 4.83M 4.84M
Weighted Average Basic & Diluted Shares Outstanding
4.83M 4.83M 4.83M
Cash Dividends to Common per Share
$4.00 $4.00 $4.00

Quarterly Income Statements for NVE

This table shows NVE's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 6/30/2022 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
4.14 6.09 4.23 8.23 4.40 4.72 4.18 3.81 4.10 4.03 3.05
Consolidated Net Income / (Loss)
4.14 6.09 4.23 8.23 4.40 4.72 4.18 3.81 4.10 4.03 3.05
Net Income / (Loss) Continuing Operations
4.14 6.09 4.23 8.23 4.40 4.72 4.18 3.81 4.10 4.03 3.05
Total Pre-Tax Income
4.99 7.56 5.23 9.31 5.80 5.13 4.96 4.57 4.88 4.86 3.57
Total Operating Income
4.71 7.21 4.82 8.90 5.37 4.62 4.47 4.06 4.39 4.40 2.96
Total Gross Profit
5.68 8.32 5.92 10 6.75 5.53 5.40 5.35 5.81 5.81 4.27
Total Revenue
7.34 11 7.40 13 8.83 7.13 6.76 7.08 6.78 6.76 5.06
Operating Revenue
7.34 11 7.40 13 8.83 7.13 6.76 7.08 6.78 6.76 5.06
Total Cost of Revenue
1.65 2.40 1.48 2.53 2.08 1.60 1.36 1.75 0.98 0.95 0.80
Operating Cost of Revenue
1.65 2.40 1.48 2.53 2.08 1.60 1.36 1.74 0.98 0.95 0.80
Other Cost of Revenue
- 0.00 0.00 - - - 0.00 - - 0.00 0.00
Total Operating Expenses
0.97 1.11 1.10 1.36 1.38 0.91 0.93 1.28 1.42 1.42 1.30
Selling, General & Admin Expense
0.37 0.44 0.40 0.75 0.48 0.43 0.39 0.47 0.54 0.57 0.43
Research & Development Expense
0.60 0.67 0.70 0.61 0.70 0.68 0.54 0.81 0.88 0.85 0.87
Total Other Income / (Expense), net
0.28 0.35 0.41 0.41 0.44 0.51 0.49 0.51 0.49 0.46 0.61
Interest & Investment Income
0.28 0.35 0.41 0.41 0.44 0.51 0.49 0.51 0.49 0.46 0.47
Other Income / (Expense), net
- - - - - - 0.00 - - - 0.14
Income Tax Expense
0.85 1.47 0.99 1.08 1.40 0.41 0.78 0.76 0.79 0.83 0.52
Basic Earnings per Share
$0.86 $1.26 $0.88 $1.70 $0.91 $0.98 $0.87 $0.78 $0.85 $0.83 $0.63
Weighted Average Basic Shares Outstanding
4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.84M
Diluted Earnings per Share
$0.86 $1.26 $0.88 $1.70 $0.91 $0.98 $0.87 $0.78 $0.85 $0.83 $0.63
Weighted Average Diluted Shares Outstanding
4.83M 4.83M 4.83M 4.83M 4.84M 4.84M 4.84M 4.84M 4.84M 4.84M 4.84M
Weighted Average Basic & Diluted Shares Outstanding
- 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.84M
Cash Dividends to Common per Share
$1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00

Annual Cash Flow Statements for NVE

This table details how cash moves in and out of NVE's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 3/31/2022 3/31/2023 3/31/2024
Net Change in Cash & Equivalents
0.02 -8.78 8.61
Net Cash From Operating Activities
13 19 18
Net Cash From Continuing Operating Activities
13 19 18
Net Income / (Loss) Continuing Operations
15 23 17
Consolidated Net Income / (Loss)
15 23 17
Depreciation Expense
0.42 0.20 0.31
Amortization Expense
- 0.06 -0.11
Non-Cash Adjustments To Reconcile Net Income
0.08 0.06 0.15
Changes in Operating Assets and Liabilities, net
-2.51 -3.92 0.77
Net Cash From Investing Activities
7.02 -8.53 9.58
Net Cash From Continuing Investing Activities
7.02 -8.53 9.58
Purchase of Property, Plant & Equipment
-0.48 -0.94 -0.02
Purchase of Investments
0.00 -28 -6.10
Sale and/or Maturity of Investments
7.50 21 16
Other Investing Activities, net
0.00 0.10 0.00
Net Cash From Financing Activities
-19 -19 -19
Net Cash From Continuing Financing Activities
-19 -19 -19
Repurchase of Common Equity
-0.16 -0.02 0.00
Payment of Dividends
-19 -19 -19
Issuance of Debt
- -0.00 0.12
Cash Income Taxes Paid
2.52 4.50 4.54

Quarterly Cash Flow Statements for NVE

This table details how cash moves in and out of NVE's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 6/30/2022 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents
2.85 -9.72 -1.55 -0.36 -0.23 5.51 -2.27 5.60 -4.28 -2.91 2.39
Net Cash From Operating Activities
3.33 6.02 5.40 4.34 5.03 5.36 4.73 3.13 5.85 2.13 3.84
Net Cash From Continuing Operating Activities
3.33 6.02 5.40 4.34 5.03 5.36 4.73 3.13 5.85 2.13 3.84
Net Income / (Loss) Continuing Operations
4.14 6.09 4.23 8.23 4.40 4.72 4.18 3.81 4.10 4.03 3.05
Consolidated Net Income / (Loss)
4.14 6.09 4.23 8.23 4.40 4.72 4.18 3.81 4.10 4.03 3.05
Depreciation Expense
0.09 0.07 0.03 0.01 0.08 0.08 0.08 0.15 0.08 0.08 0.08
Amortization Expense
- - - - -0.02 -0.02 -0.04 - -0.05 -0.07 -0.09
Non-Cash Adjustments To Reconcile Net Income
0.01 0.04 0.01 0.01 0.22 -0.11 0.01 0.01 0.02 0.09 -0.03
Changes in Operating Assets and Liabilities, net
-0.90 -0.18 1.13 -3.97 0.34 0.69 0.50 -0.74 1.71 -1.99 0.83
Net Cash From Investing Activities
4.35 -11 -2.12 0.15 -0.54 4.99 -2.17 7.30 -5.30 -0.21 3.27
Net Cash From Continuing Investing Activities
4.35 -11 -2.12 0.15 -0.54 4.99 -2.17 7.30 -5.30 -0.21 3.27
Purchase of Property, Plant & Equipment
-0.02 - -0.88 -0.03 -0.00 -0.01 - - -0.92 -0.21 -0.04
Purchase of Investments
-4.98 -20 -1.24 -1.82 -3.94 - -2.17 - -6.58 - -4.70
Sale and/or Maturity of Investments
9.25 9.50 - 2.00 3.40 5.00 - 7.30 2.20 - 8.01
Net Cash From Financing Activities
-4.83 -4.83 -4.83 -4.85 -4.71 -4.83 -4.83 -4.83 -4.83 -4.83 -4.72
Net Cash From Continuing Financing Activities
-4.83 -4.83 -4.83 -4.85 -4.71 -4.83 -4.83 -4.83 -4.83 -4.83 -4.72
Payment of Dividends
-4.83 -4.83 -4.83 -4.83 -4.83 -4.83 -4.83 -4.83 -4.83 -4.83 -4.84
Other Financing Activities, net
0.00 - - - 0.12 - - - 0.00 -0.00 0.11
Cash Income Taxes Paid
1.28 0.01 2.85 0.37 1.20 1.93 0.57 0.85 0.00 1.81 0.97

Annual Balance Sheets for NVE

This table presents NVE's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 3/31/2022 3/31/2023 3/31/2024
Total Assets
67 69 67
Total Current Assets
42 31 33
Cash & Equivalents
10 1.67 10
Short-Term Investments
21 16 12
Accounts Receivable
4.70 6.52 3.14
Inventories, net
5.09 6.42 7.16
Prepaid Expenses
0.42 0.66 0.69
Plant, Property, & Equipment, net
-1.20 -0.61 -0.90
Plant, Property & Equipment, gross
9.74 10 11
Accumulated Depreciation
11 11 11
Total Noncurrent Assets
28 39 34
Long-Term Investments
24 36 31
Noncurrent Note & Lease Receivables
1.81 1.96 1.96
Noncurrent Deferred & Refundable Income Taxes
0.48 0.57 1.45
Other Noncurrent Operating Assets
1.17 0.43 0.29
Total Liabilities & Shareholders' Equity
67 69 67
Total Liabilities
2.90 2.18 1.21
Total Current Liabilities
2.46 1.83 1.04
Accounts Payable
0.94 0.28 0.13
Accrued Expenses
1.36 1.38 0.73
Other Current Liabilities
0.16 0.18 0.18
Total Noncurrent Liabilities
0.45 0.34 0.18
Other Noncurrent Operating Liabilities
0.45 0.34 0.18
Total Equity & Noncontrolling Interests
65 67 66
Total Preferred & Common Equity
65 67 66
Total Common Equity
65 67 66
Common Stock
19 19 20
Retained Earnings
46 49 47
Accumulated Other Comprehensive Income / (Loss)
-0.32 -1.21 -0.78

Quarterly Balance Sheets for NVE

This table presents NVE's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 12/31/2022 6/30/2023 9/30/2023 12/31/2023 6/30/2024 9/30/2024 12/31/2024
Total Assets
68 66 68 68 68 67 66 65
Total Current Assets
26 22 26 25 29 31 34 30
Cash & Equivalents
3.58 2.03 1.44 6.95 4.68 6.01 3.10 5.49
Short-Term Investments
10 10 12 7.22 14 16 20 15
Accounts Receivable
5.86 2.10 5.40 2.92 2.25 2.10 2.95 1.36
Inventories, net
5.79 6.46 6.29 6.97 7.35 7.16 7.42 7.79
Prepaid Expenses
0.60 0.92 0.71 1.06 0.60 0.52 0.53 0.74
Plant, Property, & Equipment, net
0.44 -0.53 -0.68 1.21 -0.83 -0.06 0.07 0.02
Plant, Property & Equipment, gross
11 10 10 12 11 11 12 12
Accumulated Depreciation
11 11 11 11 11 11 12 12
Total Noncurrent Assets
41 44 43 41 39 35 32 34
Long-Term Investments
40 41 40 40 36 32 28 30
Noncurrent Note & Lease Receivables
- 1.93 1.96 - 1.96 1.96 1.96 1.96
Noncurrent Deferred & Refundable Income Taxes
0.89 0.86 0.72 1.40 1.29 1.59 1.52 1.69
Other Noncurrent Operating Assets
0.49 0.46 0.39 0.36 0.32 0.26 0.22 0.95
Total Liabilities & Shareholders' Equity
68 66 68 68 68 67 66 65
Total Liabilities
3.79 2.27 1.57 1.22 1.03 1.83 1.02 1.62
Total Current Liabilities
3.42 1.88 1.27 0.96 0.81 1.69 0.93 0.75
Accounts Payable
0.40 0.47 0.16 0.24 0.17 0.17 0.17 0.15
Accrued Expenses
- 1.25 0.94 0.54 0.46 1.34 0.58 0.51
Other Current Liabilities
0.16 0.16 0.18 0.18 0.18 0.18 0.18 0.08
Total Noncurrent Liabilities
0.37 0.40 0.30 0.26 0.22 0.13 0.09 0.86
Other Noncurrent Operating Liabilities
0.37 0.40 0.30 0.26 0.22 0.13 0.09 0.86
Total Equity & Noncontrolling Interests
64 63 67 66 67 65 65 63
Total Preferred & Common Equity
64 63 67 66 67 65 65 63
Total Common Equity
64 63 67 66 67 65 65 63
Common Stock
19 19 19 20 20 20 20 20
Retained Earnings
46 46 49 48 48 46 45 43
Accumulated Other Comprehensive Income / (Loss)
-1.78 -1.45 -1.45 -1.50 -0.75 -0.75 -0.07 -0.30

Annual Metrics And Ratios for NVE

This table displays calculated financial ratios and metrics derived from NVE's official financial filings.

Metric 2023 2024
Period end date 3/31/2023 3/31/2024
Growth Metrics
- -
Revenue Growth
41.75% -22.09%
EBITDA Growth
54.60% -27.72%
EBIT Growth
57.05% -27.79%
NOPAT Growth
58.69% -27.87%
Net Income Growth
56.43% -24.54%
EPS Growth
56.67% -24.68%
Operating Cash Flow Growth
52.69% -4.42%
Free Cash Flow Firm Growth
77.84% -3.42%
Invested Capital Growth
43.93% -8.66%
Revenue Q/Q Growth
18.89% -16.09%
EBITDA Q/Q Growth
22.82% -20.43%
EBIT Q/Q Growth
23.09% -20.73%
NOPAT Q/Q Growth
25.10% -22.39%
Net Income Q/Q Growth
24.16% -20.51%
EPS Q/Q Growth
24.01% -20.63%
Operating Cash Flow Q/Q Growth
5.16% -6.22%
Free Cash Flow Firm Q/Q Growth
14.35% -7.17%
Invested Capital Q/Q Growth
38.81% 5.62%
Profitability Metrics
- -
Gross Margin
78.92% 77.28%
EBITDA Margin
67.71% 62.81%
Operating Margin
67.04% 62.14%
EBIT Margin
67.04% 62.14%
Profit (Net Income) Margin
59.33% 57.46%
Tax Burden Percent
83.77% 83.67%
Interest Burden Percent
105.65% 110.52%
Effective Tax Rate
16.23% 16.33%
Return on Invested Capital (ROIC)
184.07% 117.60%
ROIC Less NNEP Spread (ROIC-NNEP)
181.83% 114.53%
Return on Net Nonoperating Assets (RNNOA)
-149.60% -91.78%
Return on Equity (ROE)
34.48% 25.82%
Cash Return on Invested Capital (CROIC)
148.05% 126.65%
Operating Return on Assets (OROA)
37.51% 27.23%
Return on Assets (ROA)
33.20% 25.18%
Return on Common Equity (ROCE)
34.48% 25.82%
Return on Equity Simple (ROE_SIMPLE)
33.83% 26.12%
Net Operating Profit after Tax (NOPAT)
21 15
NOPAT Margin
56.15% 51.99%
Net Nonoperating Expense Percent (NNEP)
2.24% 3.07%
Cost of Revenue to Revenue
21.08% 22.76%
SG&A Expenses to Revenue
5.13% 5.94%
R&D to Revenue
6.75% 9.16%
Operating Expenses to Revenue
11.89% 15.11%
Earnings before Interest and Taxes (EBIT)
26 19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
26 19
Valuation Ratios
- -
Price to Book Value (P/BV)
5.54 6.48
Price to Tangible Book Value (P/TBV)
5.54 6.48
Price to Revenue (P/Rev)
9.71 14.27
Price to Earnings (P/E)
16.37 24.83
Dividend Yield
5.20% 4.55%
Earnings Yield
6.11% 4.03%
Enterprise Value to Invested Capital (EV/IC)
23.11 29.59
Enterprise Value to Revenue (EV/Rev)
8.32 12.49
Enterprise Value to EBITDA (EV/EBITDA)
12.29 19.88
Enterprise Value to EBIT (EV/EBIT)
12.41 20.10
Enterprise Value to NOPAT (EV/NOPAT)
14.82 24.02
Enterprise Value to Operating Cash Flow (EV/OCF)
16.67 20.40
Enterprise Value to Free Cash Flow (EV/FCFF)
18.42 22.31
Leverage & Solvency
- -
Debt to Equity
0.00 0.00
Long-Term Debt to Equity
0.00 0.00
Financial Leverage
-0.82 -0.80
Leverage Ratio
1.04 1.03
Compound Leverage Factor
1.10 1.13
Debt to Total Capital
0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00%
Debt to EBITDA
0.00 0.00
Net Debt to EBITDA
0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00
Debt to NOPAT
0.00 0.00
Net Debt to NOPAT
0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00
Altman Z-Score
105.73 213.50
Noncontrolling Interest Sharing Ratio
0.00% 0.00%
Liquidity Ratios
- -
Current Ratio
16.80 32.05
Quick Ratio
12.93 24.47
Cash Flow Metrics
- -
Free Cash Flow to Firm (FCFF)
17 17
Operating Cash Flow to CapEx
2,040.15% 109,063.48%
Free Cash Flow to Firm to Interest Expense
0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00
Efficiency Ratios
- -
Asset Turnover
0.56 0.44
Accounts Receivable Turnover
6.81 6.17
Inventory Turnover
1.40 1.00
Fixed Asset Turnover
0.00 0.00
Accounts Payable Turnover
13.16 33.17
Days Sales Outstanding (DSO)
53.57 59.20
Days Inventory Outstanding (DIO)
260.44 365.31
Days Payable Outstanding (DPO)
27.73 11.00
Cash Conversion Cycle (CCC)
286.28 413.51
Capital & Investment Metrics
- -
Invested Capital
14 13
Invested Capital Turnover
3.28 2.26
Increase / (Decrease) in Invested Capital
4.20 -1.19
Enterprise Value (EV)
318 372
Market Capitalization
372 425
Book Value per Share
$13.89 $13.57
Tangible Book Value per Share
$13.89 $13.57
Total Capital
67 66
Total Debt
0.00 0.00
Total Long-Term Debt
0.00 0.00
Net Debt
-53 -53
Capital Expenditures (CapEx)
0.94 0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)
12 9.96
Debt-free Net Working Capital (DFNWC)
29 32
Net Working Capital (NWC)
29 32
Net Nonoperating Expense (NNE)
-1.21 -1.63
Net Nonoperating Obligations (NNO)
-53 -53
Total Depreciation and Amortization (D&A)
0.26 0.20
Debt-free, Cash-free Net Working Capital to Revenue
30.77% 33.41%
Debt-free Net Working Capital to Revenue
75.69% 107.90%
Net Working Capital to Revenue
75.69% 107.90%
Earnings Adjustments
- -
Adjusted Basic Earnings per Share
$4.70 $3.54
Adjusted Weighted Average Basic Shares Outstanding
4.83M 4.83M
Adjusted Diluted Earnings per Share
$4.70 $3.54
Adjusted Weighted Average Diluted Shares Outstanding
4.83M 4.84M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
4.83M 4.83M
Normalized Net Operating Profit after Tax (NOPAT)
21 15
Normalized NOPAT Margin
56.15% 51.99%
Pre Tax Income Margin
70.82% 68.67%
Debt Service Ratios
- -
EBIT to Interest Expense
0.00 0.00
NOPAT to Interest Expense
0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00
Payout Ratios
- -
Dividend Payout Ratio
85.15% 112.89%
Augmented Payout Ratio
85.24% 112.89%

Quarterly Metrics And Ratios for NVE

This table displays calculated financial ratios and metrics derived from NVE's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 6/30/2022 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.56% 57.07% 17.66% 90.45% 20.38% -33.44% -8.72% -44.65% -23.19% -5.25% -25.06%
EBITDA Growth
12.94% 70.44% 17.54% 114.22% 13.10% -35.80% -6.92% -52.74% -18.73% -5.73% -31.48%
EBIT Growth
14.66% 76.35% 19.37% 117.47% 13.94% -35.93% -7.23% -54.40% -18.24% -4.84% -30.75%
NOPAT Growth
16.80% 70.74% 20.53% 121.53% 4.28% -26.78% -3.40% -56.95% -9.56% -14.36% -32.94%
Net Income Growth
15.66% 67.02% 22.10% 115.74% 6.37% -22.44% -1.11% -53.68% -6.95% -14.76% -27.15%
EPS Growth
16.22% 68.00% 22.22% 115.19% 5.81% -22.22% -1.14% -54.12% -6.59% -15.31% -27.59%
Operating Cash Flow Growth
0.93% 92.52% 104.45% 27.52% 50.86% -10.97% -12.37% -27.87% 16.46% -60.20% -18.77%
Free Cash Flow Firm Growth
4,559.83% -10.84% -28.81% 1,470.20% -166.51% -22.57% -3.27% 24.88% 156.87% 44.82% -12.27%
Invested Capital Growth
0.00% 49.61% 26.22% 43.93% 0.00% 23.30% 20.05% -8.66% -11.46% 7.53% 8.11%
Revenue Q/Q Growth
9.18% 46.09% -30.94% 72.90% -30.99% -19.23% -5.29% 4.84% -4.24% -0.36% -25.09%
EBITDA Q/Q Growth
15.34% 51.71% -33.41% 83.84% -39.10% -13.88% -3.46% -6.65% 4.72% -0.10% -29.84%
EBIT Q/Q Growth
15.06% 53.02% -33.15% 84.76% -39.71% -13.95% -3.21% -9.19% 8.09% 0.15% -29.57%
NOPAT Q/Q Growth
9.91% 48.70% -32.80% 101.71% -48.26% 4.41% -11.34% -10.11% 8.69% -1.13% -30.57%
Net Income Q/Q Growth
8.49% 47.11% -30.52% 94.56% -46.51% 7.26% -11.41% -8.88% 7.46% -1.74% -24.28%
EPS Q/Q Growth
8.86% 46.51% -30.16% 93.18% -46.47% 7.69% -11.22% -10.34% 8.97% -2.35% -24.10%
Operating Cash Flow Q/Q Growth
-2.18% 80.72% -10.34% -19.55% 15.72% 6.65% -11.74% -33.78% 86.84% -63.55% 80.13%
Free Cash Flow Firm Q/Q Growth
5,233.07% -82.57% -23.12% 99.23% -349.15% 120.29% -3.96% 157.21% 13.46% -48.33% -41.82%
Invested Capital Q/Q Growth
-100.00% 0.00% -3.59% 38.81% -4.06% -3.97% -6.13% 5.62% -7.00% 16.63% -5.63%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
77.48% 77.58% 80.03% 80.24% 76.45% 77.57% 79.94% 75.46% 85.62% 85.98% 84.25%
EBITDA Margin
65.41% 67.93% 65.50% 69.65% 61.46% 65.53% 66.79% 59.47% 65.03% 65.20% 61.07%
Operating Margin
64.22% 67.27% 65.11% 69.58% 60.79% 64.76% 66.18% 57.32% 64.70% 65.04% 58.48%
EBIT Margin
64.22% 67.27% 65.11% 69.58% 60.79% 64.76% 66.18% 57.32% 64.70% 65.04% 61.15%
Profit (Net Income) Margin
56.43% 56.82% 57.17% 64.33% 49.86% 66.22% 61.93% 53.83% 60.41% 59.57% 60.21%
Tax Burden Percent
82.90% 80.55% 80.98% 88.41% 75.86% 92.05% 84.32% 83.46% 83.92% 82.84% 85.38%
Interest Burden Percent
106.01% 104.87% 108.43% 104.58% 108.13% 111.09% 111.00% 112.52% 111.25% 110.57% 115.32%
Effective Tax Rate
17.10% 19.45% 19.02% 11.59% 24.14% 7.95% 15.68% 16.54% 16.08% 17.16% 14.62%
Return on Invested Capital (ROIC)
0.00% 196.08% 190.82% 201.63% 277.46% 187.64% 181.57% 108.22% 121.00% 112.05% 103.51%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 195.59% 190.23% 200.96% 276.22% 186.76% 180.80% 107.42% 120.22% 111.32% 102.52%
Return on Net Nonoperating Assets (RNNOA)
0.00% -170.14% -164.20% -165.33% -221.37% -153.80% -150.45% -86.08% -97.43% -89.00% -82.91%
Return on Equity (ROE)
0.00% 25.94% 26.62% 36.30% 56.08% 33.84% 31.11% 22.14% 23.56% 23.05% 20.60%
Cash Return on Invested Capital (CROIC)
0.00% 152.54% 169.96% 148.05% 127.56% 154.06% 164.69% 126.65% 133.33% 102.75% 99.09%
Operating Return on Assets (OROA)
0.00% 30.39% 31.32% 38.93% 35.47% 34.64% 35.25% 25.12% 26.64% 26.66% 23.76%
Return on Assets (ROA)
0.00% 25.67% 27.50% 36.00% 29.10% 35.42% 32.99% 23.59% 24.87% 24.42% 23.40%
Return on Common Equity (ROCE)
0.00% 25.94% 26.62% 36.30% 56.08% 33.84% 31.11% 22.14% 23.56% 23.05% 20.60%
Return on Equity Simple (ROE_SIMPLE)
0.00% 27.48% 28.80% 0.00% 34.50% 32.47% 32.35% 0.00% 25.92% 24.86% 23.80%
Net Operating Profit after Tax (NOPAT)
3.91 5.81 3.90 7.87 4.07 4.25 3.77 3.39 3.68 3.64 2.53
NOPAT Margin
53.23% 54.18% 52.72% 61.51% 46.11% 59.61% 55.80% 47.84% 54.30% 53.88% 49.93%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.49% 0.59% 0.67% 1.24% 0.88% 0.77% 0.80% 0.78% 0.73% 0.99%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - 5.66% - - - 4.01%
Cost of Revenue to Revenue
22.52% 22.42% 19.97% 19.76% 23.55% 22.43% 20.06% 24.67% 14.38% 14.02% 15.75%
SG&A Expenses to Revenue
5.06% 4.06% 5.45% 5.88% 5.38% 6.08% 5.76% 6.69% 7.97% 8.41% 8.59%
R&D to Revenue
8.20% 6.25% 9.47% 4.78% 7.88% 9.58% 8.01% 11.45% 12.95% 12.54% 17.18%
Operating Expenses to Revenue
13.27% 10.32% 14.92% 10.66% 15.67% 12.81% 13.77% 18.01% 20.92% 20.95% 25.76%
Earnings before Interest and Taxes (EBIT)
4.71 7.21 4.82 8.90 5.37 4.62 4.47 4.06 4.39 4.40 3.10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4.80 7.28 4.85 8.91 5.43 4.67 4.51 4.21 4.41 4.41 3.09
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 3.18 4.50 5.54 6.63 5.67 5.41 6.48 5.50 5.95 6.25
Price to Tangible Book Value (P/TBV)
0.00 3.18 4.50 5.54 6.63 5.67 5.41 6.48 5.50 5.95 6.25
Price to Revenue (P/Rev)
7.32 6.53 8.88 9.71 11.10 10.42 10.15 14.27 12.85 14.10 15.32
Price to Earnings (P/E)
13.20 11.58 15.64 16.37 19.22 17.45 16.73 24.83 21.21 23.95 26.27
Dividend Yield
9.71% 9.53% 6.76% 5.20% 4.38% 5.13% 5.36% 4.55% 5.42% 5.01% 4.91%
Earnings Yield
7.57% 8.64% 6.39% 6.11% 5.20% 5.73% 5.98% 4.03% 4.71% 4.18% 3.81%
Enterprise Value to Invested Capital (EV/IC)
0.00 14.51 23.42 23.11 29.36 25.46 25.67 29.59 25.95 24.54 26.68
Enterprise Value to Revenue (EV/Rev)
0.00 4.81 7.22 8.32 9.76 8.93 8.61 12.49 10.94 12.23 13.37
Enterprise Value to EBITDA (EV/EBITDA)
0.00 7.33 11.02 12.29 14.64 13.51 12.95 19.88 17.15 19.20 21.63
Enterprise Value to EBIT (EV/EBIT)
0.00 7.45 11.15 12.41 14.75 13.62 13.08 20.10 17.31 19.34 21.74
Enterprise Value to NOPAT (EV/NOPAT)
0.00 9.05 13.53 14.82 17.93 16.07 15.31 24.02 20.12 23.12 25.94
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 9.70 12.80 16.67 18.66 16.05 15.71 20.40 15.92 21.13 22.96
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 11.41 15.37 18.42 46.03 18.25 17.01 22.31 18.28 24.75 27.98
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -0.87 -0.86 -0.82 -0.80 -0.82 -0.83 -0.80 -0.81 -0.80 -0.81
Leverage Ratio
0.00 1.04 1.03 1.04 1.02 1.04 1.03 1.03 1.03 1.02 1.02
Compound Leverage Factor
0.00 1.09 1.12 1.09 1.11 1.15 1.14 1.15 1.14 1.12 1.18
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 34.25 77.45 104.93 170.54 187.22 212.50 212.78 119.39 229.26 148.19
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.00 7.65 11.64 16.80 20.46 26.14 36.08 32.05 18.58 36.32 40.30
Quick Ratio
0.00 5.78 7.70 12.93 14.95 17.78 26.27 24.47 14.04 27.79 28.95
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
14 2.40 1.84 3.67 -9.14 1.85 1.78 4.58 5.20 2.69 1.56
Operating Cash Flow to CapEx
13,596.50% 0.00% 611.21% 15,410.72% 121,648.56% 42,535.84% 0.00% 0.00% 638.47% 1,021.63% 10,286.90%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.45 0.48 0.56 0.58 0.53 0.53 0.44 0.41 0.41 0.39
Accounts Receivable Turnover
0.00 7.11 12.53 6.81 7.36 8.24 16.36 6.17 7.40 9.33 14.27
Inventory Turnover
0.00 1.43 1.31 1.40 1.35 1.20 1.10 1.00 0.84 0.70 0.59
Fixed Asset Turnover
0.00 85.92 0.00 0.00 0.00 43.93 0.00 0.00 0.00 43.03 0.00
Accounts Payable Turnover
0.00 17.28 24.38 13.16 53.34 23.89 23.58 33.17 34.06 24.26 27.46
Days Sales Outstanding (DSO)
0.00 51.33 29.13 53.57 49.56 44.29 22.32 59.20 49.29 39.11 25.58
Days Inventory Outstanding (DIO)
0.00 254.77 278.40 260.44 270.51 303.00 333.18 365.31 432.53 522.42 618.32
Days Payable Outstanding (DPO)
0.00 21.12 14.97 27.73 6.84 15.28 15.48 11.00 10.72 15.05 13.29
Cash Conversion Cycle (CCC)
0.00 284.98 292.56 286.28 313.23 332.01 340.02 413.51 471.11 546.49 630.61
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 10 9.92 14 13 13 12 13 12 14 13
Invested Capital Turnover
0.00 3.62 3.62 3.28 6.02 3.15 3.25 2.26 2.23 2.08 2.07
Increase / (Decrease) in Invested Capital
-9.84 3.41 2.06 4.20 13 2.40 1.99 -1.19 -1.51 0.96 0.97
Enterprise Value (EV)
0.00 149 232 318 388 323 306 372 304 335 344
Market Capitalization
199 203 286 372 441 377 360 425 357 386 394
Book Value per Share
$0.00 $13.19 $13.14 $13.89 $13.78 $13.76 $13.78 $13.57 $13.42 $13.42 $13.03
Tangible Book Value per Share
$0.00 $13.19 $13.14 $13.89 $13.78 $13.76 $13.78 $13.57 $13.42 $13.42 $13.03
Total Capital
0.00 64 63 67 67 66 67 66 65 65 63
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 -53 -54 -53 -53 -54 -55 -53 -53 -51 -50
Capital Expenditures (CapEx)
0.02 0.00 0.88 0.03 0.00 0.01 0.00 0.00 0.92 0.21 0.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 8.84 7.60 12 11 9.99 9.38 9.96 8.09 9.97 9.13
Debt-free Net Working Capital (DFNWC)
0.00 23 20 29 25 24 28 32 30 33 30
Net Working Capital (NWC)
0.00 23 20 29 25 24 28 32 30 33 30
Net Nonoperating Expense (NNE)
-0.23 -0.28 -0.33 -0.36 -0.33 -0.47 -0.41 -0.42 -0.41 -0.38 -0.52
Net Nonoperating Obligations (NNO)
0.00 -53 -54 -53 -53 -54 -55 -53 -53 -51 -50
Total Depreciation and Amortization (D&A)
0.09 0.07 0.03 0.01 0.06 0.06 0.04 0.15 0.02 0.01 -0.00
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 28.45% 23.63% 30.77% 27.99% 27.62% 26.42% 33.41% 29.14% 36.42% 35.53%
Debt-free Net Working Capital to Revenue
0.00% 73.23% 62.07% 75.69% 62.24% 66.82% 79.97% 107.90% 107.23% 120.17% 114.92%
Net Working Capital to Revenue
0.00% 73.23% 62.07% 75.69% 62.24% 66.82% 79.97% 107.90% 107.23% 120.17% 114.92%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $1.26 $0.88 $1.70 $0.91 $0.98 $0.87 $0.78 $0.85 $0.83 $0.63
Adjusted Weighted Average Basic Shares Outstanding
0.00 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.84M
Adjusted Diluted Earnings per Share
$0.00 $1.26 $0.88 $1.70 $0.91 $0.98 $0.87 $0.78 $0.85 $0.83 $0.63
Adjusted Weighted Average Diluted Shares Outstanding
0.00 4.83M 4.83M 4.83M 4.84M 4.84M 4.84M 4.84M 4.84M 4.84M 4.84M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.83M 4.84M
Normalized Net Operating Profit after Tax (NOPAT)
3.91 5.81 3.90 7.87 4.07 4.25 3.77 3.39 3.68 3.64 2.53
Normalized NOPAT Margin
53.23% 54.18% 52.72% 61.51% 46.11% 59.61% 55.80% 47.84% 54.30% 53.88% 49.93%
Pre Tax Income Margin
68.08% 70.54% 70.60% 72.77% 65.73% 71.94% 73.45% 64.50% 71.98% 71.91% 70.51%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
128.31% 110.37% 105.74% 85.15% 84.17% 89.51% 89.71% 112.89% 114.96% 119.93% 129.04%
Augmented Payout Ratio
128.31% 110.37% 105.74% 85.24% 84.17% 89.51% 89.71% 112.89% 114.96% 119.93% 129.04%

Financials Breakdown Chart

Key Financial Trends

NVEC’s recent financial statements show a company with very strong profitability, an exceptionally conservative balance sheet, and consistent cash generation. Over the last several quarters, revenue has been somewhat choppy, but margins have remained high and the company continues to generate enough operating cash to fund dividends and investments without taking on meaningful debt.

  • Profitability remains strong. In Q3 2025, NVEC generated $3.0 million in net income on $5.1 million of revenue, for a net margin of about 60%.
  • Operating cash flow is solid. The company produced $3.8 million in operating cash flow in Q3 2025, outpacing net income and indicating good earnings quality.
  • The balance sheet is extremely healthy. As of Q3 2025, NVEC had $64.6 million in assets versus only $1.6 million in total liabilities, leaving it with roughly $63.0 million in equity.
  • Liquidity is abundant. Cash and short-term investments totaled about $20.4 million in Q3 2025, giving the company plenty of flexibility.
  • Investment income is a meaningful contributor. In Q3 2025, interest and investment income added $474,000 to pre-tax income, helping support profitability.
  • Dividends are well covered. The company paid $1.00 per share in dividends in Q3 2025, but still finished the quarter with positive operating cash flow and a growing cash balance.
  • Working capital remains positive. Current assets of $30.3 million far exceeded current liabilities of $751,000 in Q3 2025.
  • Share count appears stable. Weighted average diluted shares were 4.84 million in Q3 2025, similar to prior quarters, which supports per-share earnings.
  • Revenue has been volatile quarter to quarter. Revenue was $7.1 million in Q4 2024, $6.8 million in Q1 2025, $6.8 million in Q2 2025, and $5.1 million in Q3 2025.
  • The company holds a large investment portfolio. Long-term investments were $29.7 million in Q3 2025, so results are somewhat influenced by market and rate conditions.
  • Q3 2025 revenue declined year over year. Revenue fell from $6.8 million in Q3 2024 to $5.1 million in Q3 2025, suggesting softer demand or a weaker sales mix.
  • Cash declined in Q3 2025. Net change in cash and equivalents was positive before investing and financing, but the quarter still ended with cash and equivalents at $5.5 million, below prior levels after dividend payments and portfolio activity.
  • Dividends consume a large portion of cash generation. Quarterly dividend payments around $4.8 million are substantial relative to operating cash flow, which means the payout depends heavily on continued earnings and investment income.

Bottom line: NVEC looks like a financially conservative, highly profitable small-cap company with a strong balance sheet and reliable cash generation. The main risk for investors is not leverage or solvency, but rather the inconsistency of revenue and the company’s dependence on sustaining high margins and investment income to support its dividend.

06/12/26 08:45 PM ETAI Generated. May Contain Errors.

NVE Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NVE's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

NVE's net income appears to be on an upward trend, with a most recent value of $17.12 million in 2024, rising from $14.51 million in 2022. The previous period was $22.69 million in 2023. See where experts think NVE is headed by visiting NVE's forecast page.

NVE's total operating income in 2024 was $18.52 million, based on the following breakdown:
  • Total Gross Profit: $23.03 million
  • Total Operating Expenses: $4.50 million

Over the last 2 years, NVE's total revenue changed from $26.99 million in 2022 to $29.80 million in 2024, a change of 10.4%.

NVE's total liabilities were at $1.21 million at the end of 2024, a 44.3% decrease from 2023, and a 58.3% decrease since 2022.

In the past 2 years, NVE's cash and equivalents has ranged from $1.67 million in 2023 to $10.45 million in 2022, and is currently $10.28 million as of their latest financial filing in 2024.

Over the last 1 years, NVE's book value per share changed from 13.89 in 2023 to 13.57 in 2024, a change of -2.3%.



Financial statements for NASDAQ:NVEC last updated on 4/7/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners